Not a member?
*Includes patients who completed trials for higher DEXILANT doses.3
The most commonly reported adverse reactions in patients 12–17 years of age (≥5%) were headache, abdominal pain, diarrhea, nasopharyngitis, and oropharyngeal pain.1
DEXILANT (dexlansoprazole) 30 mg and 60 mg delayed‑release capsules are indicated in patients ≥ age 12 years for:
Use of DEXILANT in patients age 12 to 17 years is supported by evidence from adequate and well‑controlled studies of DEXILANT capsules in adults with additional safety, efficacy and pharmacokinetic data in patients age 12 to 17 years.
The safety and effectiveness of DEXILANT have not been established in patients < 12 years of age.
Please see full Prescribing Information, including Medication Guide for DEXILANT.